Chad E. Davis, Ph.D.

Chad E. Davis, Ph.D. counsels companies, investors, and entrepreneurs on intellectual property matters, especially patent matters. Dr. Davis has extensive experience in prosecution and strategic development of worldwide patent portfolios, intellectual property due diligence, risk assessment through, for example, validity and infringement analyses, post-grant patent proceedings, and intellectual property contracts.

Dr. Davis represents clients in a diverse range of technologies, including pharmaceuticals, drug delivery technologies, crystal forms, organic dyes, chemical processes, polymers, proteins, antibodies, stem cell technology, medical diagnostics, medical imaging, microfluidic devices, adhesives, analytical chemistry, foams, cosmetics, and optical technologies.  For companies developing pharmaceuticals, Dr. Davis provides counsel through all aspects of the business cycle with particular acumen for developing and implementing strategies to maximize worldwide patent and regulatory exclusivities for the pharmaceutical product.

In 2023, Dr. Davis was named a Leading Lawyer by The Legal 500 US for Intellectual Property: Patents: Prosecution, being described as having “a business-centric approach to IP, incorporating business strategy in his recommendations on patent prosecutions”, and was previously listed in the category in 2022 and 2020. He is routinely recognized as an IAM Patent 1000 World’s Leading Patent Practitioner in Massachusetts, who in 2023, described him as someone who “thinks holistically on how to protect his clients’ IP” and “has an excellent grasp of the science, but also knows how to use this knowledge to achieve his clients’ business goals.” In 2022, IAM Patent 1000 praised him as someone who "works creatively and pragmatically and has exceptional analytical skills, great strategic vision and a gift for communicating complex IP insights so they are easy to understand." In 2022, Dr. Davis was shortlisted as a U.S. Rising Star for Intellectual Property by LMG Life Sciences. In 2021, IAM Patent 1000 referred to Dr. Davis as "another go-to in Boston and an essential partner to drug companies throughout all phases of the product development lifecycle." In 2019, Dr. Davis was recognized by The Legal 500 US for Industry focus: Healthcare: Life Sciences. Dr. Davis was also recognized by the National Law Journal as a "Rising Star" in the Boston area. Prior to joining Dechert, Dr. Davis was a partner at another law firm.